Literature DB >> 34088928

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time.

Sang-Min Kim1, Sang-Il Kim2, Gina Yu3, June-Sung Kim1, Seok In Hong1, Bora Chae1, Yo Sep Shin1, Youn-Jung Kim1, Seongsoo Jang4, Won Young Kim5.   

Abstract

Coagulopathy is frequent in septic shock and plays a key role in multiple organ dysfunction. The aim of this study is to investigate application values of thromboelastography (TEG) for outcome in septic shock patients with a normal value of prothrombin time (PT) and active partial thromboplastin time (aPTT). Prospective observational study using 1298 consecutive septic shock patients with TEG at admission was conducted at the emergency department (ED) of a tertiary care hospital in South Korea between 2016 and 2019. After excluding overt-disseminated intravascular coagulation (DIC) defined by scoring system, we included patients with a normal value of international normalized ratio ≤ 1.3 and aPTT ≤ 34 s. The primary outcome was 28-day mortality. 893 patients were included and 129 patients with overt DIC were excluded. Of the 764 remaining patients, 414 (54.2%) patients showed normal PT and aPTT (28-day mortality rate, 11.4%). TEG values such as reaction time, kinetic time (K), alpha angle (α), maximum amplitude (MA) and lysis index (LY 30) showed no significant mean difference between the survivor and non-survivor groups. However, hypocoagulable TEG values such as α < 53° (12.0% vs. 23.4%; p = 0.039), and MA < 50 mm (6.3% vs. 21.3%; p = 0.002) were significantly higher in the non-survived group. In multivariate analysis, hypocoagulable state (defined as K > 3 and α < 53 and MA < 50) was independent factors associated with increased risk of death (OR 4.882 [95% CI, 1.698-14.035]; p = 0.003). In conclusion, septic shock patients with normal PT and aPTT can be associated with impaired TEG profile, such as hypocoagulability, associated with increased mortality.

Entities:  

Year:  2021        PMID: 34088928     DOI: 10.1038/s41598-021-91221-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

Review 1.  DIC: which laboratory tests are most useful.

Authors:  Marcel Levi; Joost C Meijers
Journal:  Blood Rev       Date:  2010-10-14       Impact factor: 8.250

Review 2.  Liver disease, coagulation testing, and hemostasis.

Authors:  Valerie L Ng
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

3.  Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke.

Authors:  Mark M McDonald; Jeremy Wetzel; Stuart Fraser; Andrea Elliott; Ritvij Bowry; Jorge F Kawano-Castillo; Chunyan Cai; Navdeep Sangha; Jessica Messier; Amanda Hassler; Joancy Archeval-Lao; Stephanie A Parker; Mohammad H Rahbar; Evan G Pivalizza; Tiffany R Chang; James C Grotta
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

4.  Thromboelastography in patients with severe sepsis: a prospective cohort study.

Authors:  Nicolai Haase; Sisse Rye Ostrowski; Jørn Wetterslev; Theis Lange; Morten Hylander Møller; Hamid Tousi; Morten Steensen; Frank Pott; Peter Søe-Jensen; Jonas Nielsen; Peter Buhl Hjortrup; Pär Ingemar Johansson; Anders Perner
Journal:  Intensive Care Med       Date:  2014-11-21       Impact factor: 17.440

5.  Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units.

Authors:  Timothy S Walsh; Simon J Stanworth; Robin J Prescott; Robert J Lee; Douglas M Watson; Duncan Wyncoll
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

Review 6.  Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm.

Authors:  H Lier; M Vorweg; A Hanke; K Görlinger
Journal:  Hamostaseologie       Date:  2013-01-10       Impact factor: 1.778

7.  Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.

Authors:  Mirka Sivula; Ville Pettilä; Tomi T Niemi; Marjut Varpula; Anne H Kuitunen
Journal:  Blood Coagul Fibrinolysis       Date:  2009-09       Impact factor: 1.276

8.  Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis.

Authors:  Christopher Gonano; Christian Sitzwohl; Eva Meitner; Christian Weinstabl; Stephan C Kettner
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  TEG in the monitoring of coagulation changes in patients with sepsis and the clinical significance.

Authors:  Wenyan Zhou; Wenjie Zhou; Jijia Bai; Shenmao Ma; Qinfu Liu; Xigang Ma
Journal:  Exp Ther Med       Date:  2019-03-05       Impact factor: 2.447

10.  Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study.

Authors:  Fritz Daudel; Ulf Kessler; Hélène Folly; Jasmin S Lienert; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2009-03-30       Impact factor: 9.097

View more
  1 in total

1.  Construction of Standard Fast Medical Procedures for Traumatic Shock and Its Application Effects.

Authors:  Yan Wang; Siqi Luo
Journal:  Emerg Med Int       Date:  2022-10-11       Impact factor: 1.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.